Drug Development

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Development of Gamma-Delta T-Cell Therapies

Activation and expansion are essential for success in both autologous and allogeneic therapies.

QbD for Small-Molecule Continuous Process Development

Continuous manufacturing and a quality-by-design development approach are a natural fit.

Early Development Challenges in IND Applications

June 03, 2022

Collecting relevant data, planning ahead, and communicating with regulatory bodies in pre-IND meeting programs can help companies to avoid roadblocks in IND applications.

Connecting the Dots for Pharma

June 02, 2022

The inaugural Connect in Pharma event will take place on 14 and 15 September in Geneva, Switzerland.

Lonza, IBF Collaborate to Support Development and Manufacturing of Biologics and Small Molecules

May 26, 2022

Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.

Lubrizol Launches Apisolex Technology

May 26, 2022

Lubrizol has launched Apisolex technology to improve solubility and simplify the manufacturing of parenteral drug products.

New Guidelines Aim to Advance Pediatric Drug Development

May 24, 2022

A new initiative aims to speed the approval of and access to new drugs for young patients around the world, while limiting the number of children needed for testing in clinical trials.

Pandemic Science Hub Launches at University of Edinburgh

May 24, 2022

Investment has been made into a new science hub at the University of Edinburgh for the development of treatments for lung infections and future pandemics.

Demonstrating a Fully Continuous Bioprocess

May 16, 2022

Flexible and efficient methods are needed for biopharmaceutical manufacturing.

Manufacturing OSD Forms: Key Trends Shaping the Industry

May 16, 2022

The latest manufacturing technologies are essential for helping pharmaceutical formulators meet up-and-coming trends in OSD treatments.

Opportunities for Growth and Breakthroughs for Cell and Gene Therapies

May 15, 2022

CGTs offer hope for the future of treatments, but the costly manufacturing, slow turnaround time, and need for supplies hinder progress.

Converting Injectable Therapies to Combination Drug-Device Products

May 15, 2022

The author describes how to seize market opportunities while navigating the requirements of both drug therapies and delivery devices.